<DOC>
	<DOCNO>NCT00511550</DOCNO>
	<brief_summary>Peripheral blood stem cell ( PBSCs ) collect follow stimulation filgrastim commonly use autologous hematopoietic transplant . PBSCs also use syngeneic allogeneic hematopoietic transplant involve HLA-matched sibling donor . However , many issue remain unanswered use PBSCs allogeneic transplant effect filgrastim healthy individual . The purpose study determine effectiveness filgrastim stimulate PBSCs hematopoietic cell transplant involve unrelated donor determine effect donation process unrelated stem cell donor .</brief_summary>
	<brief_title>Filgrastim-Mobilized Peripheral Blood Stem Cells Allogeneic Transplantation With Unrelated Donors</brief_title>
	<detailed_description>This study establish evaluate system supply peripheral blood stem cell ( PBSC ) product use unrelated donor hematopoietic stem cell ( HSC ) transplantation . The protocol describe process donor identification , education evaluation . Procedures administration monitor stem cell mobilize agent filgrastim include . The study also describe procedure collection PBSC product leukapheresis include provision indefinite donor follow-up .</detailed_description>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Healthy adult Pregnancy uninterruptible breastfeeding . Sensitivity filgrastim E. coliderived recombinant protein product . History autoimmune disorder , include rheumatic disease thyroid disorder . Exception : As bone marrow donation , donor history thyroid disease undergone successful therapy may suitable . History deep vein thrombosis pulmonary embolism . Thrombocytopenia &lt; 150 x 10 ( 9 ) /L ( &lt; 150,000/uL ) baseline evaluation . Current treatment lithium . Drug interaction filgrastim lithium , may potentiate release neutrophil , full evaluate . Positive HemoglobinSolubility ( e.g . SickleDex equivalent ) test . Donors receive experimental therapy investigational agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>peripheral blood stem cell</keyword>
	<keyword>filgrastim-mobilized</keyword>
	<keyword>allogeneic transplantation</keyword>
	<keyword>Unrelated Donors allogeneic transplantation</keyword>
</DOC>